Chemerin mRNA and protein localized to the endothelium, smooth muscle, and fat cells of human vessels, placing it in close proximity to its receptors, suggesting that it could act as a locally released mediator and levels could be elevated in pathologies, such as obesity and metabolic syndrome. This evidence concerns the gene RARRES2 and metabolic syndrome.